| Position: | Partner |
| Practice Areas: | Patent |
| Office: | Guangzhou |
| Qualifications: | Patent Attorney; Chinese Bar Qualification |
| Education: | PhD, Biological Science University of California, Irvine (US) MS, Biological Sciences State University of New York at Binghamton(US) |
Dr. Wenwen WANG received her Ph.D. in U.S. and joined Advance China IP Law Office in 2013. She worked before asuniversity research assistant and then as the director of an industrial R&D laboratory supervising research and IP work. She has been providing IP services to various domestic and foreign clients in patent drafting, prosecution, analysis, and consulting of patentability and infringement in the fields of biotech, pharmaceuticals, chemistry, and medical devices. Dr. Wang has extensive experiences in patent applications in China, US, Europe, and other countries. Her clients are for example Amorepacific, GENEXINE, Sorrento therapeutics, Oxford Immunotec, Resmed, University of California, University of Queensland, Seoul National University, and Nanyang Technological University. She also participated in a number of IP investigation and research projects funded by SIPO (now CNIPA) and WIPO.
Affiliations
• Member of All China Patent AgentsAssociation (ACPAA)
• Member of American IntellectualProperty Law Association (AIPLA)
• Committee Member of Asian IPPractice Committee of Intellectual Property Owner Association
Publications
ResearchReport on Intellectual Property Environment in Latin America, a researchproject funded by SIPO (now CNIPA), October 2015
MongolianIntellectual Property Environmental Research Report, a research project fundedby SIPO (now CNIPA), June 2016
UnderstandingRestriction Requirement and Election of Species in US Patent Prosecution, published on Patent Analyst, December 22, 2017
Respondingto Restriction Requirement and Election of Species in US Patent Prosecution, published on Patent Analyst, December 29, 2017
